Sipuleucel-T

Grey

Brand Name(s):Provenge

Indication:Prostate cancer metastatic, hormone-refractory

Rationale:1

Considered:Apr-07

Review Date:Mar-20

Comments:
NICE TA 332
Treating asymptomatic or minimally symptomatic metastatic hormone-relapsed prostate cancer. Full guidance at:
https://www.nice.org.uk/guidance/ta332/resources/guidance-sipuleucelt-for-treating-asymptomatic-or-minimally-symptomatic-metastatic-hormonerelapsed-prostate-cancer-pdf

February 2015